# Clinical and transcriptional response to the long‐acting interleukin‐1 blocker canakinumab in Blau syndrome–related uveitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-and-transcriptional-response-to-the-long-acting-interleukin-1-blocker/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gabriele Simonini,Zhaohui Xu,Roberto Caputo,Cinzia de Libero,Ilaria Pagnini,Virginia Pascual,Rolando Cimaz |
| Citations | 148 |
| DOI | 10.1002/art.37776 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.37776?download=true |
| OpenAlex ID | https://openalex.org/W1995106708 |
| PMID | 23124805 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Gabriele Simonini](https://scholariq.org/researchers/gabriele-simonini/)

## Paper primary topic

- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)

## Paper topics

- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.